Apollomics Inc.
APLM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 4 institutions reported holding it in 13F filings for Q2 2026, worth $223.8K in total; no superinvestor holds it.
Other share classesAPLMW
Q1 2024 vs. Q4 2023
How the institutions holding Apollomics Inc. changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 13 | 12 | −1 |
| Shares | 8.85M | 9.25M | +397.4K (+4.5%) |
| Value | $8.54M | $6.94M | −$1.60M (−18.8%) |
New holders (3)
Institutions that held Apollomics Inc. at the end of Q1 2024 but not at the end of Q4 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Powell Investment Advisors, LLC | 130,297 | $97.7K | 0.05% |
| Jane Street Group, LLC | 19,072 | $14.3K | 0.00% |
| Warberg Asset Management LLC | 10,026 | $7.32K | 0.00% |
Sold out (4)
Institutions that held Apollomics Inc. at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Citadel Advisors LLC | 54,722 | $52.8K |
| Zullo Investment Group, Inc. | 14,853 | $14.3K |
| Johnson & Johnson | 13,252 | $12.8K |
| Tower Research Capital LLC (TRC) | 13 | $13 |